Quote: IncellDx to launch Leronlimab Receptor Occu
Post# of 148154
(Total Views: 746)
Posted On: 12/12/2020 10:52:05 AM
Re: ClosetInvestor #67962
Quote: IncellDx to launch Leronlimab Receptor Occupancy Assay reagents
This is about $2 per share net asset on current on hand product.
Nader said last year that Incelldx has a deal to purchase the 2.5 kg on hand noncommercial Leron dor $1.5B or so. Can't remember the exact number.
This is about $2 per share net asset on current on hand product.
Nader said last year that Incelldx has a deal to purchase the 2.5 kg on hand noncommercial Leron dor $1.5B or so. Can't remember the exact number.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼